Lung cancer Flashcards

1
Q

What is an angiosarcoma?

A

A primary cancer forming within the blood and lymph vessels, manifesting as a malignancy of vascular endothelial cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a myxoma?

A

A tumour of connective tissue can grow within the cardiac chambers leading to occlusion of blood flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Why are cardiac cancers rare?

A

Relatively low cellular exposure to carcinogens compared to that with the lungs

Low turnover rate –> Cardiac myocytes divide very rarely (Growth is due to hyperplastic mechanisms, whereby the individual cell grows).

There is a strong selective advantage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What impact does a strong selective advantage in the heart have in terms of cancers?

A

Abnormal cells with incorrect architecture are selected against to minimise the risk of compromising cardiac function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the common causes of lung cancer?

A
Passive smoking
Asbestos exposure
Radon
Indoor cooking fumes --> wood, smoke, frying fats
Chronic lung diseases (COPD, fibrosis)
Immunodeficiency (HIV)
Familial/genetic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which cancer is centrally located, originating in the bronchial epithelium?

A

Squamous cell carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which cells are implicated in an adenocarcinoma?

A

Adenocarcinoma originate from the mucous-producing glandular tissue, located more peripherally in the lung.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which type of cancer is typically associated with a large cell lung cancer?

A

Undifferentiated heterogenous cancers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which cells are involved in a small cell lung cancer?

A

Originate from pulmonary neuroendocrine cells that are highly malignant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which lung cancers are classified as non-small cell lung cancers?

A

Squamous cell carcinoma
Adenoma carcinoma
Large cell lung cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is metaplasia?

A

Refers to the reversible change in which one adult cell is replaced by another adult cell type: adaptive in response to physiological changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is dysplasia?

A

Dysplasia refers to an abnormal pattern of growth in which aspects of cellular and architectural features of malignancy are present, this is considered to be the pre-invasive stage with an intact basement membrane (no invasion).
• Dysplasia is not reversible.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is an invasive carcinoma?

A

An invasive carcinoma is concerned with an abnormal uncontrolled growth of cancerous cell, with invasion of neighbouring tissues and the ability to metastasise (Secondary growth formation).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which type of intracellular enzyme is involved with lung cancer?

A

Tyrosine kinases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What function is performed by tyrosine kinases?

A

Tyrosine kinases are mediators of signal transduction during the cell cycle controlling cell proliferation, differentiation, and apoptosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which oncogene mutation is involved with adenocarcinoma? (15-30% of the time).

A

epidermal growth factor receptor (EGFR) tyrosine kinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the epidemiology of the EGFR tyrosine kinase mutation?

A

Mutation in 15-30% of adenocarcinoma

More so in women, Asian ethnicity, never smokers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Which lung cancer oncogene mutation is concerned with smoking?

A

BRAF (downstream cell-cycle signalling mediator).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the four main oncogenes concerned with lung cancer?

A

Epidermal growth factors receptor (EGFR) tyrosine kinases

Anaplastic lymphoma kinase (ALK) tyrosine kinase

C-ROS oncogene 1 (ROS1) receptor tyrosine kinases

BRAF (downstream cell-cycle signalling mediator)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the symptoms with lung cancer?

A
Cough
Dyspnoea
Haemoptysis 
Chest/shoulder pain 
Weight loss
fatigue 

Symptoms are non-specific

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the neurological features of metastatic disease?

A

Neurological features : focal weakness, seizures (brain metastases), spinal cord decompression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the paraneoplastic features of metastatic disease?

A

Paraneoplastic syndromes:

• Clubbing, hypercalcaemia of malignancy, hyponatremia, Cushing’s (Ectopic release of ACTH).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the three main features of metastatic disease?

A

Neurological features

Bone pain (PTH related peptides, ectopic release from lung cancer)

Paraneoplatic syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are the four main signs of metastatic lung cancer?

A

Finger clubbing

Cachexia

Horner’s syndrome

Pemberton’s sign

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Why does finger clubbing occur in metastatic disease?

A

Clubbing of the distal digits and nails due to low oxygen saturation inducing vasodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is cachexia in metastatic disease?

A

Muscle atrophy of weight loss due to reduced nutritional intake and catabolism from tumour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What is Horner’s syndrome?

A

Triad of ptosis, miosis, and ipsilateral anhidrosis (loss of sweating) occurs more frequently in patients with superior sulcus tumour –> Invades sympathetic plexus.

28
Q

What is Pemberton’s sign?

A

• Superior vena cava obstruction (Pemberton’s sign): Engorgement of the face due to reduced blood flow to the right atrium  Redness of face and swelling (Evident upon the elevation of the arms).

29
Q

What is the diagnostic strategy for lung cancer?

A

Establish most likely diagnosis
Establish fitness for investigation and treatment
Confirm diagnosis
Specific type of cancer if considering systemic treatment
Confirm staging

30
Q

What type of imaging is conducted for patients with diagnosed lung cancer?

A

A standard posteroanterior chest X-ray

Chest x-rays can be used to track pleural effusions and growth of mass.

31
Q

What are chest X-rays used for in terms of patients with lung cancer?

A

In patients with diagnosed lung cancer: Chest x-rays can be used to track pleural effusions and growth of mass.
• Detection of single or multiple pulmonary nodules
• Mass
• Lung collapse
• Mediastinal or hilar fullness.

32
Q

Which type of imaging can be used to monitor the size, location and extent of primary tumour?

A

Staging CT (chest and abdomen)

33
Q

What is the purpose performed by a staging CT in an individual with lung cancer?

A

Staging CT (Chest and abdomen)
• Size, location and extent of primary tumour
• Evaluates for hilar and/or mediastinal lymphadenopathy and distant metastases.

34
Q

Which imaging can be conducted to exclude occult metastases (cannot find location primary tumour)?

A

PET-Scan

35
Q

What function is performed by a PET scan in a patient with lung cancer?

A

Most useful to exclude occult metastases (cannot find location of primary tumour).

Activity within the mediastinum strongly leads to metastases.

36
Q

What is the ultimate investigation to confirm the diagnosis fo lung cancer?

A

Biopsy

37
Q

Which type of biopsy is conducted for peripheral lesions that are not accessible with bronchoscopy?

A

A CT-guided trans-thoracic needle aspiration

38
Q

Which type of biopsy is conducted for central airway tumours?

A

Tumours of central airways (would identify endobronchial lesions).

39
Q

How is lung cancer diagnosed from a biopsy sample?

A

Typing, subtyping and mutation testing.

40
Q

What are the three staging features of cancer?

A

T1-4: Tumour size and location
N0-3: Lymph node involvement
M0-1c: Metastases + number

41
Q

What fitness score is associated with radical treatment for lung cancer?

A

PS 0-2

42
Q

What is PS0 in terms of patient fitness?

A

Asymptomatic (Fully active, able to conduct activities of daily living and that of pre-disease without restriction.

43
Q

What PS score is given for a patient that is Symptomatic but completely ambulatory (restricted in physically strenuous activity but ambulatory, and able to carry out work of a light or sedentary nature)?

A

PS1

44
Q

What is PS2 in terms of patient fitness?

A

Symptomatic, <50% in bed during the day (ambulatory and capable of all self-care but unable to carry out any work activities, up for more than 50% of waking hours).

45
Q

What is PS3 in terms of patient fitness?

A

Symptomatic, >50% in bed, but not bedbound (capable of only limited self-care, confined to the bed for more than 50% of waking hours).

46
Q

What is PS4 in terms of patient fitness?

A

Bedbound (completely disabled, cannot conduct any self-care, totally confined to bed).

47
Q

Which patient fitness category is equal to death?

A

PS5

48
Q

Which type of surgical intervention is available for early stage disease of lung cancer?

A

Surgical resection

49
Q

What is lobectomy?

A

The removal of an entire lung lobe

50
Q

When is sublobar resection conducted in an individual with lung cancer?

A

If stage 1 (<3cm).

51
Q

What is the alternative to surgical intervention in an individual with lung cancer?

A

Radical radiotherapy

Stereotactic ablative body radiotherapy (SABR)

52
Q

What treatments are available for metastatic disease of lung cancer?

A

Immunotherapy
Chemotherapy
Tyrosine kinase inhibitor

53
Q

Which drugs are available for oncogene-directed therapy for EGFR?

A

• EGFR - Erlotinib, gefitinib, afatinib, dacomitinib, and osimertinib

54
Q

What drug is used for oncogene-directed therapy for both ALK and ROS-1 mutations?

A

Crizotinib

55
Q

What are the common side effects for systematic oncogene-directed treatments?

A

Rash
Diarrhoea
Pneumonitis

56
Q

Which receptor is exhibited by tumour cells?

A

PDL-1 receptor

57
Q

How do tumour cells evade the immune system?

A

• Tumour cells exhibit the PDL-1 receptor with the capacity to bind onto PD-1 ligands on T-cells, through this binding action, it enables to tumour cell to evade T-cell cytotoxic responses.

58
Q

How is immunotherapy used to target tumour cells?

A

In immunotherapy, the PDL-1 receptor is blocked by anti-PDL-1, this therefore enables T-cell recognition of the tumour cells –> Inducing an cytotoxic response

59
Q

What is the first line of treatment for metastatic NSCLC with no mutation (and PDL-1 >50%)?

A

Immunotherapy

Drug: Pembrolizumab, atezolizumab, nivolumab

60
Q

What are the side effects associated with immunotherapy of NSCLC?

A

Side effects:
• Generally well-tolerated
• Immune-related side effects in 10-15% (thyroid, skin, bowel, lung, liver).

61
Q

When is cytotoxic chemotherapy used?

A

First line for metastatic NSCLC with no mutation and PDL-1 <50% (in combination with immunotherapy).

62
Q

What drugs are typically used for cytotoxic chemotherapy?

A

Platinum based regimes (carboplatin, cisplatin)

63
Q

What are the side effects associated with cytotoxic chemotherapy?

A

Side effects
• Frequent: Fatigue, nausea, bone marrow suppression, nephrotoxicity.
• Quality of life poorly evaluated in trials, no evidence for improvement.

64
Q

What type of treatment should be offered as a standard to all patients with advanced stage disease?

A
  • Symptom control
  • Psychological support
  • Education
  • Practical
  • Financial support
  • Planning for end of life.
65
Q

What is the treatment outcome for early-staged disease?

A

Surgery or radiotherapy with curative intent

66
Q

What is the treatment outcome for locally advanced disease (involving thoracic lymph nodes)?

A

Surgery + adjuvant chemotherapy